Keywords:
AVP, [Arg8]vasopressin,
d(CH2)5-Tyr(Me)2AVP, [1-(β-mercapto-β,β-cyclopentamethylene-propionic acid), 2-O-methyltyrosine, 8-arginine] vasopressin,
ALVP, [1-(β-mercapto-β,β-cyclopentamethylene-propionic acid, 2-O-methyltyrosine, 8-arginine, 9-lysinamide] vasopressin,
AL(Btn)VP, [1-(β-mercapto-β,β-cyclopentamethylenepropionic acid), 2-O-methyltyrosine, 8-arginine, 9-lysinamide (Nε-biotinamidocaproamide)]-vasopressin,
PhAcALVP, [1-phenylacetyl, 2-O-methyl-d-tyrosine, 6-arginine, 8-arginine, 9-lysinamide]vasopressin,
PhAcAL(Mec)VP, [1-phenylacetyl, 2-O-methyl-d-tyrosine, 6-arginine, 8-arginine, 9-lysinamide (Nε-7-amino-4-methylcoumarin-3-acetamide)]vasopressin,
PhAcAL(Btn)VP, [1-phenylacetyl, 2-O-methyl-d-tyrosine, 6-arginine, 8-arginine-9-lysinamide (Nε-biotinamidocapro-amide)]vasopressin,
DMF, dimethylformamide,
VPR, vasopressin receptor,
NHS, N-hydroxysuccinimide
This content is only available as a PDF.
© 1994 Biochemical Society
1994
You do not currently have access to this content.